CASIMERSEN vs RISDIPLAM: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
CASIMERSEN vs RISDIPLAM: Safety Overview
| Metric | CASIMERSEN | RISDIPLAM |
|---|---|---|
| Total FAERS Reports | 767 | 3,619 |
| Deaths Reported | 7 | 336 |
| Death Rate | 0.9% | 9.3% |
| Hospitalizations | 87 | 719 |
| Average Patient Age | 14.0 yrs | 21.8 yrs |
| % Female Patients | 0.4% | 55.2% |
| FDA Approval Date | Feb 25, 2021 | Aug 7, 2020 |
| Manufacturer | Sarepta Therapeutics, Inc. | Genentech, Inc. |
| Route | N/A | ORAL |
| Marketing Status | Prescription | Prescription |